World drug report 2007 [Recurso eletrónico ]
Autor institucional: NAÇÕES UNIDAS. Office on Drugs and CrimeIdioma: Inglês.Publicação: Vienna : United Nations Office on Drugs and Crime (UNODC), 2007Descrição física: 1 CD-ROM; 12 cmISBN: 9789211482225Assunto: 238858 | 343871 | 102909 | 225700 | 343625 | 343339 | 344136 | 410454Resumo: Preface. Introduction. Explanatory notes. Executive Summary. 1. TRENDS IN WORLD DRUG MARKETS. 1.1 Overview. 1.1.1 Global evolution. 1.1.2 Global outlook. 1.2 Opium / Heroin market. 1.2.1 Summary trend / overview. 1.2.2 Production. 1.2.3 Trafficking. 1.2.4 Abuse. 1.3 Coca / Cocaine market. 1.3.1 Summary trend / overview. 1.3.2 Production. 1.3.3 Trafficking. 1.3.4 Abuse.1.4 Cannabis market. 1.4.1 Summary trend / overview. 1.4.2 Production. 1.4.3 Trafficking. 1.4.4 Abuse. 1.5 Amphetamine-type stimulants market. 1.5.1 Summary trend / overview. 1.5.2 Production. 1.5.3 Trafficking. 1.5.4 Abuse. 2. INVISIBLE EMPIRE OR INVISIBLE HAND? ORGANIZED CRIME AND TRANSNATIONAL DRUG TRAFFICKING. 2.1 Introduction. 2.2 Assessing the degree of organization. 2.3 Cocaine via Central America to the United States. 2.4 Heroin via Central Asia to the Russian Federation. 2.5 Tracking Trafficking. 3. STATISTICAL ANNEX. 3.1 Production. 3.1.1 Afghanistan. 3.1.2 Bolivia. 3.1.3 Colombia. 3.1.4 Lao PDR. 3.1.5 Myanmar. 3.1.6 Peru. 3.2 Seizures. 3.3 Seizures of illicit laboratories. 3.4 Prices. 3.4.1 Opiates: Wholesale, street prices and purity levels. 3.4.2 Cocaine: Wholesale, street prices and purity levels. 3.4.3 Cannabis: Wholesale, street prices and purity levels. 3.4.4 Amphetamine-type stimulants: Wholesale, street prices and purity levels. 3.5 Consumption. 3.5.1 Annual Prevalence. 3.5.1.1 Opiates. 3.5.1.2 Cocaine. 3.5.1.3 Cannabis. 3.5.1.4 Amphetamine-type stimulants (excluding ecstasy). 3.5.1.5 Ecstasy. 3.5.2. Treatment Demand. 3.5.2.1 Primary drugs of abuse among persons treated for drug problems in Africa. 3.5.2.2 Primary drugs of abuse among persons treated for drug problems in America. 3.5.2.3 Primary drugs of abuse among persons treated for drug problems in Asia. 3.5.2.4 Primary drugs of abuse among persons treatedfor drug problems in Europe. 3.5.2.5 Primary drugs of abuse among persons treated for drug problems in Oceania. 4. METHODOLOGY.| Item type | Current location | Call number | Copy number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
| Monografias | Biblioteca da Polícia Judiciária | PJCD112 (Browse shelf) | PJCD112 | Available | PJ1CD112_6 |
Ficheiro de 7,32 Mb em formato pdf (282 f.). Também disponível em: https://www.unodc.org/pdf/research/wdr07/WDR_2007.pdf.
Preface. Introduction. Explanatory notes. Executive Summary. 1. TRENDS IN WORLD DRUG MARKETS. 1.1 Overview. 1.1.1 Global evolution. 1.1.2 Global outlook. 1.2 Opium / Heroin market. 1.2.1 Summary trend / overview. 1.2.2 Production. 1.2.3 Trafficking. 1.2.4 Abuse. 1.3 Coca / Cocaine market. 1.3.1 Summary trend / overview. 1.3.2 Production. 1.3.3 Trafficking. 1.3.4 Abuse.1.4 Cannabis market. 1.4.1 Summary trend / overview. 1.4.2 Production. 1.4.3 Trafficking. 1.4.4 Abuse. 1.5 Amphetamine-type stimulants market. 1.5.1 Summary trend / overview. 1.5.2 Production. 1.5.3 Trafficking. 1.5.4 Abuse. 2. INVISIBLE EMPIRE OR INVISIBLE HAND? ORGANIZED CRIME AND TRANSNATIONAL DRUG TRAFFICKING. 2.1 Introduction. 2.2 Assessing the degree of organization. 2.3 Cocaine via Central America to the United States. 2.4 Heroin via Central Asia to the Russian Federation. 2.5 Tracking Trafficking. 3. STATISTICAL ANNEX. 3.1 Production. 3.1.1 Afghanistan. 3.1.2 Bolivia. 3.1.3 Colombia. 3.1.4 Lao PDR. 3.1.5 Myanmar. 3.1.6 Peru. 3.2 Seizures. 3.3 Seizures of illicit laboratories. 3.4 Prices. 3.4.1 Opiates: Wholesale, street prices and purity levels. 3.4.2 Cocaine: Wholesale, street prices and purity levels. 3.4.3 Cannabis: Wholesale, street prices and purity levels. 3.4.4 Amphetamine-type stimulants: Wholesale, street prices and purity levels. 3.5 Consumption. 3.5.1 Annual Prevalence. 3.5.1.1 Opiates. 3.5.1.2 Cocaine. 3.5.1.3 Cannabis. 3.5.1.4 Amphetamine-type stimulants (excluding ecstasy). 3.5.1.5 Ecstasy. 3.5.2. Treatment Demand. 3.5.2.1 Primary drugs of abuse among persons treated for drug problems in Africa. 3.5.2.2 Primary drugs of abuse among persons treated for drug problems in America. 3.5.2.3 Primary drugs of abuse among persons treated for drug problems in Asia. 3.5.2.4 Primary drugs of abuse among persons treatedfor drug problems in Europe. 3.5.2.5 Primary drugs of abuse among persons treated for drug problems in Oceania. 4. METHODOLOGY.
There are no comments for this item.